Xvivo Perfusion AB
STO:XVIVO
Xvivo Perfusion AB
STO:XVIVO
Price:
300
SEK
3.73%
Market Cap:
kr9.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Xvivo Perfusion AB
STO:XVIVO
|
SE |
Multiples-Based Value
The Multiples-Based Value of one
XVIVO
stock under the Base Case scenario is
104.91
SEK.
Compared to the current market price of 300 SEK,
Xvivo Perfusion AB
is
Overvalued by 65%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XVIVO
Multiples-Based Value
104.91
SEK
Overvaluation 65%
Multiples Across Competitors
XVIVO Competitors Multiples
Xvivo Perfusion AB Competitors
Xvivo Perfusion AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Xvivo Perfusion AB
STO:XVIVO
|
9.4B SEK | 11.6 | 375.5 | 56.3 | 98.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 10.7 | 39.1 | 28.4 | 34.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
61.7B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF | 3.7 | 39.1 | 15 | 29.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
97.7B DKK | 3.6 | 25.2 | 13.2 | 15.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 3.3 | 32.2 | 14 | 19.2 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.5 | 35 | 12.1 | 18.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.4T KRW | 103.5 | -38 | -88 | -83.3 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.1 | -16.3 | 17.3 | 55.9 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
927.6B JPY | 7.1 | 52.4 | 24.9 | 33.8 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 3.5 | 23.2 | 14.9 | 18.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
